Table 4.4.
Surveillance After Aortic Endograft or Aortoiliac Stenting
| Indication | Appropriate Use Score (1–9) | |||
|---|---|---|---|---|
| Baseline (Within 1 Month After the Intervention) | ||||
| 95. | • Aortic or iliac endograft | A (8) | ||
| 96. | • Aortic and iliac artery stents | A (7) | ||
| New or Worsening Lower Extremity Symptoms After Baseline Exam | ||||
|
| ||||
| 97. | • Aortic or iliac endograft | A (8) | ||
| 98. | • Aortic and iliac artery stents | A (8) | ||
| Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency During First Year | At 3 to 5 months | At 6 to 8 months | At 9 to 12 months | |
|
| ||||
| 99. | • Aortic endograft without endoleak stable and/or decreasing residual aneurysm sac size | I (3) | U (5) | U (6) |
| 100. | • Aortic endograft with endoleak and/or increasing residual aneurysm sac size | U (6) | A (8) | A (7) |
| 101. | • Aortic or iliac artery stents | I (2) | U (5) | U (6) |
| Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency After First Year | Every 6 months | Every 12 months | Every 24 months or greater | |
|
| ||||
| 102. | • Aortic endograft without endoleak stable and/or decreasing residual aneurysm sac size | I (3) | A (7) | U (5) |
| 103. | • Aortic endograft with endoleak and/or increasing residual aneurysm sac size | A (8) | A (7) | U (5) |
| 104. | • Aortic or iliac artery stents | I (2) | U (5) | U (5) |
A = appropriate; I = inappropriate; U = uncertain.